Current Problems in Pediatric and Adolescent Health Care
Volume 36, Issue 3 , Pages 78-79 , March 2006

Pediatric Rheumatology: The Future Is Now, or … “The Future’s So Bright, I Gotta Wear Shades”1

  • James N. Jarvis, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to James N. Jarvis, MD, Basic Sciences Education Bldg., BSEB #235A, Oklahoma City, OK 73104.

References 

  1. Giannini EH , Brewer EJ , Kuzmina N , Shaikov A , Maximov A , Vorontsov I  The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children’s Study Group . Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.–U.S.S.R. double-blind, placebo-controlled trial . N Eng J Med . 1992;326:1043–1049
  2. Giannini EH , Cassidy JT . Methotrexate in juvenile rheumatoid arthritis. Do the benefits outweigh the risks? . Drug Saf . 1993;9:325–339
  3. Lovell DJ , Giannini EH , Reiff A , Cawkwell GD , Silverman ED , Nocton JJ  Pediatric Rheumatology Collaborative Study Group . Etanercept in children with polyarticular juvenile rheumatoid arthritis . N Engl J Med . 2000;342:763–769

PII: S1538-5442(05)00127-6

doi: 10.1016/j.cppeds.2005.10.007

Current Problems in Pediatric and Adolescent Health Care
Volume 36, Issue 3 , Pages 78-79 , March 2006

Article Tools